CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 1 Study of the Safety and Immunogenicity of a 2-Dose Regimen of West Nile/Dengue 4-3´Δ30 Chimeric Virus Vaccine (WN/DEN4Δ30), a Live Attenuated Vaccine for West Nile Encephalitis, in Flavivirus-naïve Adults 50-65 Years of Age

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02186626
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:18.224108+00:00
Published At: 2017-02-01T00:00:00+00:00
Record Updated At: 2017-02-01
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["West Nile Virus"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-02-01"
protocolSection.identificationModule.nctId: "NCT02186626"
protocolSection.identificationModule.officialTitle: "Phase 1 Study of the Safety and Immunogenicity of a 2-Dose Regimen of West Nile/Dengue 4-3\u00b4\u039430 Chimeric Virus Vaccine (WN/DEN4\u039430), a Live Attenuated Vaccine for West Nile Encephalitis, in Flavivirus-na\u00efve Adults 50-65 Years of Age"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.